NCT01585974View on ClinicalTrials.gov

Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

151

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

November 30, 2015

Conditions
Renal Cell Carcinoma
Interventions
OTHER

No intervention

All dosage, frequency and duration for drugs will be under the decision of the treating physician

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY